Shares NexImmune, Inc. Common Stock UNDERWRITING AGREEMENTUnderwriting Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • New York
NexImmune, Inc., a Delaware corporation (the “Company”), proposes to sell [__] shares (the “Firm Stock”) of the Company’s common stock, par value $0.0001 per share (the “Common Stock”). In addition, the Company proposes to grant to the underwriters (the “Underwriters”) named in Schedule I attached to this agreement (this “Agreement”) an option to purchase up to [__] additional shares of the Common Stock on the terms set forth in Section 2 (the “Option Stock”). The Firm Stock and the Option Stock, if purchased, are hereinafter collectively called the “Stock”. This Agreement is to confirm the agreement concerning the purchase of the Stock from the Company by the Underwriters.
NEXIMMUNE, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • Delaware
THIS INDEMNIFICATION AGREEMENT (this “Agreement”) is made and entered into this th day of , 20 , by and between NexImmune, Inc. a Delaware corporation (the “Company”), and (“Indemnitee”).
SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENTInvestors’ Rights Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • Delaware
THIS SECOND AMENDED AND RESTATED INVESTORS’ RIGHTS AGREEMENT (this “Agreement”), is made as of the 27th day of November, 2019 by and among NexImmune, Inc., a Delaware corporation (the “Company”), and each of the investors listed on Schedule A hereto, each of which is referred to in this Agreement as an “Investor”, and any Additional Purchaser (as defined in the Purchase Agreement) that becomes a party to this Agreement in accordance with Section 6.9 hereof.
EMPLOYMENT AGREEMENTEmployment Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • Maryland
This Employment Agreement (this “Agreement”) is entered into as of this 6th day of January, 2020 (the “Effective Date”) by and between John Trainer (“Employee”) and Nexlmmune, Inc. (“Company”).
NEXIMMUNE, INC. STOCK OPTION AWARD AGREEMENTRestricted Stock Unit Award Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • Delaware
Pursuant to your Stock Option Grant Notice (“Grant Notice”) and this Option Agreement, NexImmune, Inc., a Delaware corporation (the “Company”) has granted you an option under its 2021 Equity Incentive Plan (the “Plan”) to purchase the number of shares of the Company’s Common Stock indicated in your Grant Notice at the exercise price indicated in your Grant Notice. Defined terms not explicitly defined in this Option Agreement but defined in the Plan will have the same definitions as in the Plan.
NEXIMMUNE-KNIGHT EMPLOYMENT AGREEMENTNeximmune-Knight Employment Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • Maryland
This Employment Agreement (this “Agreement”) is entered into as of this 6th day of January, 2021 (the “Effective Date”) by and between Robert Knight, M.D., (“Employee”) and NexImmune, Inc. (“Company”).
EMPLOYMENT AGREEMENTEmployment Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • Maryland
This Employment Agreement (this “Agreement”) is entered into as of February 3, 2021 (the “Effective Date”) by and between Scott Carmer (“Employee”) and NexImmune, Inc. (“Company”).
ContractNexImmune, Inc. • February 8th, 2021 • Pharmaceutical preparations • Delaware
THIS NOTE AND THE SECURITIES ISSUABLE UPON THE CONVERSION HEREOF HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR UNDER THE SECURITIES LAWS OF ANY STATE. THESE SECURITIES MAY NOT BE OFFERED, SOLD OR OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED EXCEPT AS PERMITTED UNDER THE ACT AND APPLICABLE STATE SECURITIES LAWS PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT OR AN EXEMPTION THEREFROM. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE ISSUER THAT SUCH OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION OTHERWISE COMPLIES WITH THE ACT AND ANY APPLICABLE STATE SECURITIES LAWS.
EMPLOYMENT AGREEMENTEmployment Agreement • February 8th, 2021 • NexImmune, Inc. • Pharmaceutical preparations • Maryland
This Employment Agreement (this “Agreement”) is entered into as of this 1st day of June, 2017 (the “Effective Date”) by and between Kristi Jones (“Employee”) and NexImmune, Inc. (“Company”).
